VI
TMDX icon

Versor Investments’s Transmedics TMDX Stock Holding History

Versor Investments’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,712
Closed -$452K – 524
2025
Q4 		$452K Buy
3,712
+552
+17% +$69.3K 0.07% 364
2025
Q3 		$355K Buy
+3,160
New +$370K 0.07% 437
2025
Q2 		– Sell
-7,476
Closed -$503K – 933
2025
Q1 		$503K Buy
+7,476
New +$514K 0.08% 410

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Versor Investments's TMDX Position: Q1 2026 in Review

Versor Investments sold out of Transmedics (TMDX) in Q1 2026, closing a stake of 3,712 shares — an estimated $452K sold.

Versor Investments first reported a position in TMDX in Q1 2025 and held it in 3 quarters. The position peaked at $503K in Q1 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Versor Investments reported no remaining Transmedics position as of Q1 2026 after selling out during the quarter.
  • Versor Investments sold 3,712 Transmedics shares in Q1 2026, an estimated $452K.
  • Versor Investments first reported a position in Transmedics in Q1 2025 and held it in 3 quarters.
  • Versor Investments's Transmedics position peaked at $503K in Q1 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Versor Investments's 13F filing for Q1 2026, filed 12 May 2026.